**INTRODUCTION:** Tendon injuries are major musculskeletal disorder with a growing demand in sports and recreation and an aging population. Polydeoxyribonucleotide (PDRN), the compound mixture of deoxyribonucleotides polymers, activates the A2A receptor subtype of adenosine receptors and then stimulates tissue growth and neogenesis.

**OBJECTIVE:** This experimental study confirms that polydeoxyribonucleotide (PDRN), extracted from the sperm of trout bred, could improve secretion of various growth factor, collagen synthesis, and restoration of tensile strength of the tendon in a rat Achilles tendon injury model.

**METHODS:** Thirty-six male Sprague--Dawley rats aged 7 weeks were divided into two groups. The Achilles tendon was transected and repaired with modified Kessler's method. In the experimental group (n = 18), the rats received daily intraperitoneal administration of PDRN (8mg/kg/day for 1, 2, 4 weeks). The control groups received same amount intraperitoneal injections of the normal saline. The rats were sacrificed at one, two and four weeks and repair site tissues were harvested. The harvested tissues were evaluated with digital calipers to measure the cross-sectional area and a mechanical testing machine for biomechanical properties. The presence of collagen type I, collagen type III, transforming growth factor β1, fibroblast growth factor, and vascular endothelial growth factor were confirmed by immunohistochemistry. For immunohistochemical analyses, each immunohistochemical evaluation was scored on a point-based system. Statistical analyses were performed using the Mann-Whitney U test.

**RESULTS:** The cross-sectional area of the tendon was significantly increased at 2 and 4 weeks in PDRN group (*p* = 0.008, 0.017). Moreover, Tendons in the PDRN group were more resistant to mechanical stress at 2 and 4 weeks compared with that of the control group (*p* = 0.041, 0.041). The levels of staining of collagen type I in the experimental group were significantly stronger than those in the control group at 2 and 4 weeks (*p* = 0.026, 0.009) Furthermore, higher expression of FGF, VEGF, and TGF-β1 was detected in the experimental group at 4 weeks compared with that in the control group (*p*= 0.041, 0.026, 0.041)

**CONCLUSION:** This study confirms that intraperitoneally injected PDRN can improve tensile strength in rat Achilles tendon healing in rats. Our results represent a new valuable agent in tendon healing.
